Cosentyx (secukinumab) is a biologic therapy that targets interleukin-17A (IL-17A), a protein involved in inflammatory conditions affecting the joints and skin. At Scottsdale Rheumatology Center, our physicians evaluate and manage Cosentyx therapy for patients throughout the Scottsdale area.
Cosentyx is commonly prescribed for:
Cosentyx dosing usually begins with weekly loading doses for the first month, followed by monthly maintenance dosing. Your rheumatologist will determine the right regimen based on your diagnosis, and our clinical team supports you through every step, from initial evaluation to ongoing follow-up visits.
Prior to starting Cosentyx, our physicians review your medical history, including screening for infections. Regular follow-up visits allow our team to track how well the therapy is working and address any concerns. Talk with your physician about the full risks and benefits of Cosentyx.
Cosentyx is covered by many insurance plans, and our office can assist with prior authorization. Visit our Health Insurance page to learn more.
Cosentyx is used for psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis.
How is Cosentyx dosed?Treatment typically starts with weekly doses for the first month, then transitions to monthly maintenance dosing.
How long before I notice improvement?Response times vary by patient; many people notice improvement within a few weeks to a few months of starting therapy.
Book an appointment to discuss Cosentyx therapy with Scottsdale Rheumatology Center.
Related: Psoriatic Arthritis | Spondyloarthritis | Infusion Suite
